Bollywood icon Shah Rukh Khan has voiced heartfelt admiration for the upcoming film Homebound, describing it as “gentle, honest and soulful.” His endorsement has amplified anticipation around the project, which has already generated interest for its intimate narrative and emotionally grounded performances. Khan, known for his discerning taste and influence across the entertainment industry, rarely comments publicly on films outside his own universe, making his praise particularly notable.

OnePlus is preparing to expand its performance-focused smartphone lineup with the upcoming launch of the OnePlus 15R on December 17. Positioned as the successor to the popular 12R, the new device is expected to feature significant upgrades in processing power, design, and battery efficiency. Anticipation within the tech community is building as the company continues its strategy of offering flagship-level performance at a competitive price point.

Instagram has introduced a new set of controls designed to give users deeper influence over the content they see on Reels, marking a significant shift in how the platform manages personalization and user engagement. The update allows individuals to fine-tune recommendations, hide specific types of content, and signal their preferences more clearly to the algorithm. By empowering users to shape their feed according to their interests, Instagram aims to address growing concerns around content relevance, algorithmic transparency, and digital well-being.

Vivo has officially released its X300 smartphone series in India, strengthening its position in the country’s premium mobile segment. The new lineup introduces advanced camera enhancements, upgraded performance capabilities, and a refined design aimed at users seeking flagship-level technology. With India emerging as one of the fastest-growing markets for high-end smartphones, Vivo’s latest launch underscores the company’s intent to compete aggressively with established rivals.

Google has rolled out its AI Plus subscription plan in India, marking a significant step in expanding access to advanced artificial intelligence capabilities for individual users and professionals. The subscription offers enhanced features, including priority access to generative AI tools, faster processing speeds, and exclusive functionalities designed to support productivity, content creation, and research-driven applications.

India’s largest airline, IndiGo, is facing heightened government scrutiny following a wave of operational disruptions that left thousands of passengers stranded across major airports. The Ministry of Civil Aviation has sought detailed reports from the carrier, citing concerns over staffing issues, scheduling gaps, and passenger inconvenience. The disruptions, which triggered delays and cancellations across multiple routes, have reignited discussions on the strain placed on airline resources amid rising demand for domestic air travel.

The initial public offering of Corona Remedies witnessed overwhelming investor enthusiasm, closing with an extraordinary 137 times subscription. The robust response underscores the strong confidence investors have in India’s expanding pharmaceutical sector and the company’s growth trajectory. Heavy bidding from qualified institutional buyers, non-institutional investors, and retail participants propelled the IPO into one of the most sought-after public issues of the year.

India’s logistics ecosystem has reached a significant milestone, with national logistics costs falling to 9% of GDP, according to Union Minister Nitin Gadkari. This marks a substantial improvement from earlier estimates that placed logistics expenses between 13% and 14%. The decline reflects the government’s sustained push toward infrastructure upgrades, multimodal connectivity, digital transformation, and streamlined regulatory frameworks.

India’s Enforcement Directorate (ED) has seized multiple bank accounts belonging to Reliance Infrastructure (R-Infra) as part of an ongoing probe into alleged violations of the Foreign Exchange Management Act (FEMA). The action involves a lien placed on funds exceeding Rs. 50 crore, following suspicions that company-linked entities routed money abroad through irregular transactions. While the agency claims funds were channelled via shell companies and questionable subcontracting structures, R-Infra has denied any wrongdoing and stated it is fully cooperating with investigators.

Cipla has expanded its chronic care portfolio with the launch of Yurpeak, a new therapy targeting obesity and diabetes—two of the fastest-growing health challenges in India. The company is positioning the drug as part of a broader strategy to address rising metabolic disorders, which have seen a sharp increase driven by lifestyle changes and urbanisation. With this launch, Cipla aims to strengthen its position in the high-potential metabolic care segment and provide clinicians with more advanced treatment options.